Current state of ST-segment myocardial infarction: evidence-based therapies and optimal patient outcomes in advanced systems of care

Cardiol Clin. 2014 Aug;32(3):371-85. doi: 10.1016/j.ccl.2014.04.002. Epub 2014 Jun 10.

Abstract

Advances in reperfusion therapy for ST-segment elevation myocardial infarction (STEMI) provide optimal patient outcomes. Reperfusion therapies, including contemporary primary percutaneous coronary intervention, represent decades of clinical evidence development in large clinical trials and national databases. However, rapid identification of STEMI and guideline-directed management of patients across broad populations have been best achieved in advanced systems of care. Current outcomes in STEMI reflect the evolution of both clinical data and idealized health care delivery networks.

Keywords: Antiplatelet therapies; Antithrombotic therapies; Coronary thrombectomy; Fibrinolysis; Primary percutaneous coronary intervention; ST-segment myocardial infarction; STEMI receiving center.

Publication types

  • Review

MeSH terms

  • Advance Care Planning*
  • Diagnostic Imaging / methods*
  • Electrocardiography*
  • Evidence-Based Medicine / methods*
  • Global Health
  • Humans
  • Incidence
  • Myocardial Infarction* / diagnosis
  • Myocardial Infarction* / epidemiology
  • Myocardial Infarction* / therapy
  • Myocardial Revascularization / methods*
  • Survival Rate / trends